Last reviewed · How we verify
Isotonic fluid
Isotonic fluid is a Crystalloid fluid / Intravenous fluid replacement Small molecule drug developed by Johns Hopkins University. It is currently in Phase 3 development for Fluid resuscitation in dehydration, Perioperative fluid management, Hypovolemic shock. Also known as: Normal saline, Lactated ringers solution, Dextrose normal saline.
Isotonic fluid restores intravascular volume and maintains osmotic balance to correct dehydration and electrolyte disturbances.
Isotonic fluid restores intravascular volume and maintains osmotic balance to correct dehydration and electrolyte disturbances. Used for Fluid resuscitation in dehydration, Perioperative fluid management, Hypovolemic shock.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Isotonic fluid |
|---|---|
| Also known as | Normal saline, Lactated ringers solution, Dextrose normal saline |
| Sponsor | Johns Hopkins University |
| Drug class | Crystalloid fluid / Intravenous fluid replacement |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Emergency Medicine / Perioperative Medicine |
| Phase | Phase 3 |
Mechanism of action
Isotonic fluids (such as normal saline or balanced crystalloids) have an osmolarity matching plasma, allowing them to distribute between intravascular and interstitial compartments without causing cellular water shifts. They are used to restore circulating volume, maintain hemodynamic stability, and correct fluid deficits in dehydrated or critically ill patients. The specific formulation determines electrolyte composition and clinical suitability for different patient populations.
Approved indications
- Fluid resuscitation in dehydration
- Perioperative fluid management
- Hypovolemic shock
- Maintenance fluid therapy in hospitalized patients
Common side effects
- Hyperchloremic acidosis
- Fluid overload / pulmonary edema
- Hyponatremia (with excessive hypotonic fluid)
- Phlebitis at infusion site
Key clinical trials
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery (PHASE1)
- Volume Kinetics of Fluid Resuscitation in Early Sepsis
- Initial Resuscitation for Acute Kidney Injury in Cirrhosis (NA)
- Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications (PHASE4)
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions. (NA)
- Role of Prophylactic Aggressive Hydration to Prevent Post-ERCP Pancreatitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isotonic fluid CI brief — competitive landscape report
- Isotonic fluid updates RSS · CI watch RSS
- Johns Hopkins University portfolio CI
Frequently asked questions about Isotonic fluid
What is Isotonic fluid?
How does Isotonic fluid work?
What is Isotonic fluid used for?
Who makes Isotonic fluid?
Is Isotonic fluid also known as anything else?
What drug class is Isotonic fluid in?
What development phase is Isotonic fluid in?
What are the side effects of Isotonic fluid?
Related
- Drug class: All Crystalloid fluid / Intravenous fluid replacement drugs
- Manufacturer: Johns Hopkins University — full pipeline
- Therapeutic area: All drugs in Critical Care / Emergency Medicine / Perioperative Medicine
- Indication: Drugs for Fluid resuscitation in dehydration
- Indication: Drugs for Perioperative fluid management
- Indication: Drugs for Hypovolemic shock
- Also known as: Normal saline, Lactated ringers solution, Dextrose normal saline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing